Infectious Disease Diagnostics Market 2027 by Coverage, Product, Disease Indication, Technology, Test Location, End User and Geography | The Insight Partners

Infectious Disease Diagnostics Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Coverage : Product ( Kits and Reagents, Instruments ); Disease Indication ( HIV, Hepatitis, Healthcare Associated Infections (HAIs), Human Papillomavirus (HPV), Tuberculosis (TB), Influenza, Other Disease Indications, , ); Technology ( Immunodiagnostics, Polymerase Chain Reaction, Next Generation Sequencing, Other Technology ); Test Location ( Laboratory Testing, Point of Care Testing, ); End User ( Hospitals, Pathology or Diagnostic Laboratories, Research Institutes, Home-Care Settings, Other End User ) and Geography

Report Code: TIPHE100001430 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Covid
MARKET INTRODUCTION

Infectious disease are caused by microorganisms such as fungi, virus, bacteria, and other organism species. Infectious disease diagnostics are the procedures utilized by hospitals, clinical laboratories, and others to detect or identify the foreign antigen/organism by using various diagnostic tests. These tests help in the identification of the type of pathogen. Also, the degree of the extent to which the infection is spread in the body. The diagnostic procedure may be carried out with the help of conventional diagnostic tests or point-of-care testing tools.

MARKET DYNAMICS

Global infectious disease diagnostic market is anticipated to be driven by various factors such as the rising prevalence of infectious and vector-borne diseases, and advancement in molecular and immunodiagnostics is projected to propel the growth of the global infectious disease diagnostics market. However, the lack of compiled regulatory guidelines and lack of centralized laboratory facilities in developing and under-developed countries are expected to hinder the market growth of the market. The immunodiagnostic kits and home-based point-of-care diagnostic for the detection of various diseases are expected to be one of the most prevailing trends in the infectious disease diagnostics market.

MARKET SCOPE

The "Global Infectious disease diagnostics market analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of infectious disease diagnostics market with detailed market segmentation by product, application, end user, and geography. Global infectious disease diagnostic market is anticipated to witness high growth during the forecast period. The report provides key statistics on the market status of the leading infectious disease diagnostics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global infectious disease diagnostics market is segmented on the basis of product, disease indication, technology, test location, end user. On the basis of product, the global infectious disease diagnostics market is segmented into reagents & kits and instruments. Based on disease indication, the market is segmented into HIV, hepatitis, healthcare associated infections (HIAs), human papillomavirus (HPV), tuberculosis, influenza, and others. Based on the technology, the market is segmented into immunodiagnostics, polymerase chain reaction (PCR), next generation sequencing (NGS), and others. On the basis of test location, the global infectious disease diagnostics market is segmented in to laboratory testing and point-of-care testing. Similarly, on the basis of end user, the global infectious disease diagnostics market is segmented in to hospitals, pathology/diagnostic, laboratories, research institutes, home-care settings, and others

Get more information on this report :

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global infectious disease diagnostics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The infectious disease diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting infectious disease diagnostics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the infectious disease diagnostics market in these regions.

Get more information on this report :



MARKET PLAYERS


The reports cover key developments in the infectious disease diagnostics market as organic and inorganic growth strategies. The various firm are focusing on organic growth strategies such as product launch, product approvals and others. Inorganic growth strategies activities observed in the market were partnership & collaborations and acquisitions. These activities have acted as a way for the expansion of business and customer base of market players. The market payers from infectious disease diagnostics market are anticipated to lucrative growth opportunities in the future with the rising demand for infectious disease diagnostics market in the global market. Below is the list of few companies operating in the infectious disease diagnostics market.

The report also includes the profiles of key infectious disease diagnostics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

  • Danaher
  • Abbott
  • BD
  • F. Hoffmann-La Roche Ltd
  • Trinity Biotech
  • Cardinal Health
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • AccuBioTech Co., Ltd.
  • ACON Laboratories, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Get more information on this report :

TABLE OF CONTENTS

 1. INTRODUCTION
 1.1. SCOPE OF THE STUDY
 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
 1.3. MARKET SEGMENTATION
 1.3.1 Infectious Disease Diagnostics Market - By Product
 1.3.2 Infectious Disease Diagnostics Market - By Disease Indication
 1.3.3 Infectious Disease Diagnostics Market - By Technology
 1.3.4 Infectious Disease Diagnostics Market - By Test Location
 1.3.5 Infectious Disease Diagnostics Market - By End User
 1.3.6 Infectious Disease Diagnostics Market - By Region
 1.3.6.1 By Country

 2. KEY TAKEAWAYS

 3. RESEARCH METHODOLOGY

 4. INFECTIOUS DISEASE DIAGNOSTICS MARKET LANDSCAPE
 4.1. OVERVIEW
 4.2. PEST ANALYSIS
 4.2.1 North America - Pest Analysis
 4.2.2 Europe - Pest Analysis
 4.2.3 Asia-Pacific - Pest Analysis
 4.2.4 Middle East and Africa - Pest Analysis
 4.2.5 South and Central America - Pest Analysis
 4.3. EXPERT OPINIONS

 5. INFECTIOUS DISEASE DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
 5.1. KEY MARKET DRIVERS
 5.2. KEY MARKET RESTRAINTS
 5.3. KEY MARKET OPPORTUNITIES
 5.4. FUTURE TRENDS
 5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC

 6. INFECTIOUS DISEASE DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
 6.1. INFECTIOUS DISEASE DIAGNOSTICS - GLOBAL MARKET OVERVIEW
 6.2. INFECTIOUS DISEASE DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2027
 6.3. MARKET POSITIONING/MARKET SHARE

 7. INFECTIOUS DISEASE DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
 7.1. OVERVIEW
 7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
 7.3. KITS AND REAGENTS
 7.3.1. Overview
 7.3.2. Kits and Reagents Market Forecast and Analysis
 7.4. INSTRUMENTS
 7.4.1. Overview
 7.4.2. Instruments Market Forecast and Analysis

 8. INFECTIOUS DISEASE DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE INDICATION
 8.1. OVERVIEW
 8.2. DISEASE INDICATION MARKET FORECASTS AND ANALYSIS
 8.3. HIV
 8.3.1. Overview
 8.3.2. HIV Market Forecast and Analysis
 8.4. HEPATITIS
 8.4.1. Overview
 8.4.2. Hepatitis Market Forecast and Analysis
 8.5. HEALTHCARE ASSOCIATED INFECTIONS (HAIS)
 8.5.1. Overview
 8.5.2. Healthcare Associated Infections (HAIs) Market Forecast and Analysis
 8.6. HUMAN PAPILLOMAVIRUS (HPV)
 8.6.1. Overview
 8.6.2. Human Papillomavirus (HPV) Market Forecast and Analysis
 8.7. TUBERCULOSIS (TB)
 8.7.1. Overview
 8.7.2. Tuberculosis (TB) Market Forecast and Analysis
 8.8. INFLUENZA
 8.8.1. Overview
 8.8.2. Influenza Market Forecast and Analysis
 8.9. OTHER DISEASE INDICATIONS
 8.9.1. Overview
 8.9.2. Other Disease Indications Market Forecast and Analysis
 8.10.
 8.10.1. Overview
 8.10.2. Market Forecast and Analysis
 8.11.
 8.11.1. Overview
 8.11.2. Market Forecast and Analysis

 9. INFECTIOUS DISEASE DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
 9.1. OVERVIEW
 9.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
 9.3. IMMUNODIAGNOSTICS
 9.3.1. Overview
 9.3.2. Immunodiagnostics Market Forecast and Analysis
 9.4. POLYMERASE CHAIN REACTION
 9.4.1. Overview
 9.4.2. Polymerase Chain Reaction Market Forecast and Analysis
 9.5. NEXT GENERATION SEQUENCING
 9.5.1. Overview
 9.5.2. Next Generation Sequencing Market Forecast and Analysis
 9.6. OTHER TECHNOLOGY
 9.6.1. Overview
 9.6.2. Other Technology Market Forecast and Analysis

 10. INFECTIOUS DISEASE DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - TEST LOCATION
 10.1. OVERVIEW
 10.2. TEST LOCATION MARKET FORECASTS AND ANALYSIS
 10.3. LABORATORY TESTING
 10.3.1. Overview
 10.3.2. Laboratory Testing Market Forecast and Analysis
 10.4. POINT OF CARE TESTING
 10.4.1. Overview
 10.4.2. Point of Care Testing Market Forecast and Analysis
 10.5.
 10.5.1. Overview
 10.5.2. Market Forecast and Analysis

 11. INFECTIOUS DISEASE DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
 11.1. OVERVIEW
 11.2. END USER MARKET FORECASTS AND ANALYSIS
 11.3. HOSPITALS
 11.3.1. Overview
 11.3.2. Hospitals Market Forecast and Analysis
 11.4. PATHOLOGY OR DIAGNOSTIC LABORATORIES
 11.4.1. Overview
 11.4.2. Pathology or Diagnostic Laboratories Market Forecast and Analysis
 11.5. RESEARCH INSTITUTES
 11.5.1. Overview
 11.5.2. Research Institutes Market Forecast and Analysis
 11.6. HOME-CARE SETTINGS
 11.6.1. Overview
 11.6.2. Home-Care Settings Market Forecast and Analysis
 11.7. OTHER END USER
 11.7.1. Overview
 11.7.2. Other End User Market Forecast and Analysis

 12. INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
 12.1. NORTH AMERICA
 12.1.1 North America Infectious Disease Diagnostics Market Overview
 12.1.2 North America Infectious Disease Diagnostics Market Forecasts and Analysis
 12.1.3 North America Infectious Disease Diagnostics Market Forecasts and Analysis - By Product
 12.1.4 North America Infectious Disease Diagnostics Market Forecasts and Analysis - By Disease Indication
 12.1.5 North America Infectious Disease Diagnostics Market Forecasts and Analysis - By Technology
 12.1.6 North America Infectious Disease Diagnostics Market Forecasts and Analysis - By Test Location
 12.1.7 North America Infectious Disease Diagnostics Market Forecasts and Analysis - By End User
 12.1.8 North America Infectious Disease Diagnostics Market Forecasts and Analysis - By Countries
 12.1.8.1 United States Infectious Disease Diagnostics Market
 12.1.8.1.1 United States Infectious Disease Diagnostics Market by Product
 12.1.8.1.2 United States Infectious Disease Diagnostics Market by Disease Indication
 12.1.8.1.3 United States Infectious Disease Diagnostics Market by Technology
 12.1.8.1.4 United States Infectious Disease Diagnostics Market by Test Location
 12.1.8.1.5 United States Infectious Disease Diagnostics Market by End User
 12.1.8.2 Canada Infectious Disease Diagnostics Market
 12.1.8.2.1 Canada Infectious Disease Diagnostics Market by Product
 12.1.8.2.2 Canada Infectious Disease Diagnostics Market by Disease Indication
 12.1.8.2.3 Canada Infectious Disease Diagnostics Market by Technology
 12.1.8.2.4 Canada Infectious Disease Diagnostics Market by Test Location
 12.1.8.2.5 Canada Infectious Disease Diagnostics Market by End User
 12.1.8.3 Mexico Infectious Disease Diagnostics Market
 12.1.8.3.1 Mexico Infectious Disease Diagnostics Market by Product
 12.1.8.3.2 Mexico Infectious Disease Diagnostics Market by Disease Indication
 12.1.8.3.3 Mexico Infectious Disease Diagnostics Market by Technology
 12.1.8.3.4 Mexico Infectious Disease Diagnostics Market by Test Location
 12.1.8.3.5 Mexico Infectious Disease Diagnostics Market by End User
 12.2. EUROPE
 12.2.1 Europe Infectious Disease Diagnostics Market Overview
 12.2.2 Europe Infectious Disease Diagnostics Market Forecasts and Analysis
 12.2.3 Europe Infectious Disease Diagnostics Market Forecasts and Analysis - By Product
 12.2.4 Europe Infectious Disease Diagnostics Market Forecasts and Analysis - By Disease Indication
 12.2.5 Europe Infectious Disease Diagnostics Market Forecasts and Analysis - By Technology
 12.2.6 Europe Infectious Disease Diagnostics Market Forecasts and Analysis - By Test Location
 12.2.7 Europe Infectious Disease Diagnostics Market Forecasts and Analysis - By End User
 12.2.8 Europe Infectious Disease Diagnostics Market Forecasts and Analysis - By Countries
 12.2.8.1 Germany Infectious Disease Diagnostics Market
 12.2.8.1.1 Germany Infectious Disease Diagnostics Market by Product
 12.2.8.1.2 Germany Infectious Disease Diagnostics Market by Disease Indication
 12.2.8.1.3 Germany Infectious Disease Diagnostics Market by Technology
 12.2.8.1.4 Germany Infectious Disease Diagnostics Market by Test Location
 12.2.8.1.5 Germany Infectious Disease Diagnostics Market by End User
 12.2.8.2 France Infectious Disease Diagnostics Market
 12.2.8.2.1 France Infectious Disease Diagnostics Market by Product
 12.2.8.2.2 France Infectious Disease Diagnostics Market by Disease Indication
 12.2.8.2.3 France Infectious Disease Diagnostics Market by Technology
 12.2.8.2.4 France Infectious Disease Diagnostics Market by Test Location
 12.2.8.2.5 France Infectious Disease Diagnostics Market by End User
 12.2.8.3 Italy Infectious Disease Diagnostics Market
 12.2.8.3.1 Italy Infectious Disease Diagnostics Market by Product
 12.2.8.3.2 Italy Infectious Disease Diagnostics Market by Disease Indication
 12.2.8.3.3 Italy Infectious Disease Diagnostics Market by Technology
 12.2.8.3.4 Italy Infectious Disease Diagnostics Market by Test Location
 12.2.8.3.5 Italy Infectious Disease Diagnostics Market by End User
 12.2.8.4 Spain Infectious Disease Diagnostics Market
 12.2.8.4.1 Spain Infectious Disease Diagnostics Market by Product
 12.2.8.4.2 Spain Infectious Disease Diagnostics Market by Disease Indication
 12.2.8.4.3 Spain Infectious Disease Diagnostics Market by Technology
 12.2.8.4.4 Spain Infectious Disease Diagnostics Market by Test Location
 12.2.8.4.5 Spain Infectious Disease Diagnostics Market by End User
 12.2.8.5 United Kingdom Infectious Disease Diagnostics Market
 12.2.8.5.1 United Kingdom Infectious Disease Diagnostics Market by Product
 12.2.8.5.2 United Kingdom Infectious Disease Diagnostics Market by Disease Indication
 12.2.8.5.3 United Kingdom Infectious Disease Diagnostics Market by Technology
 12.2.8.5.4 United Kingdom Infectious Disease Diagnostics Market by Test Location
 12.2.8.5.5 United Kingdom Infectious Disease Diagnostics Market by End User
 12.3. ASIA-PACIFIC
 12.3.1 Asia-Pacific Infectious Disease Diagnostics Market Overview
 12.3.2 Asia-Pacific Infectious Disease Diagnostics Market Forecasts and Analysis
 12.3.3 Asia-Pacific Infectious Disease Diagnostics Market Forecasts and Analysis - By Product
 12.3.4 Asia-Pacific Infectious Disease Diagnostics Market Forecasts and Analysis - By Disease Indication
 12.3.5 Asia-Pacific Infectious Disease Diagnostics Market Forecasts and Analysis - By Technology
 12.3.6 Asia-Pacific Infectious Disease Diagnostics Market Forecasts and Analysis - By Test Location
 12.3.7 Asia-Pacific Infectious Disease Diagnostics Market Forecasts and Analysis - By End User
 12.3.8 Asia-Pacific Infectious Disease Diagnostics Market Forecasts and Analysis - By Countries
 12.3.8.1 Australia Infectious Disease Diagnostics Market
 12.3.8.1.1 Australia Infectious Disease Diagnostics Market by Product
 12.3.8.1.2 Australia Infectious Disease Diagnostics Market by Disease Indication
 12.3.8.1.3 Australia Infectious Disease Diagnostics Market by Technology
 12.3.8.1.4 Australia Infectious Disease Diagnostics Market by Test Location
 12.3.8.1.5 Australia Infectious Disease Diagnostics Market by End User
 12.3.8.2 China Infectious Disease Diagnostics Market
 12.3.8.2.1 China Infectious Disease Diagnostics Market by Product
 12.3.8.2.2 China Infectious Disease Diagnostics Market by Disease Indication
 12.3.8.2.3 China Infectious Disease Diagnostics Market by Technology
 12.3.8.2.4 China Infectious Disease Diagnostics Market by Test Location
 12.3.8.2.5 China Infectious Disease Diagnostics Market by End User
 12.3.8.3 India Infectious Disease Diagnostics Market
 12.3.8.3.1 India Infectious Disease Diagnostics Market by Product
 12.3.8.3.2 India Infectious Disease Diagnostics Market by Disease Indication
 12.3.8.3.3 India Infectious Disease Diagnostics Market by Technology
 12.3.8.3.4 India Infectious Disease Diagnostics Market by Test Location
 12.3.8.3.5 India Infectious Disease Diagnostics Market by End User
 12.3.8.4 Japan Infectious Disease Diagnostics Market
 12.3.8.4.1 Japan Infectious Disease Diagnostics Market by Product
 12.3.8.4.2 Japan Infectious Disease Diagnostics Market by Disease Indication
 12.3.8.4.3 Japan Infectious Disease Diagnostics Market by Technology
 12.3.8.4.4 Japan Infectious Disease Diagnostics Market by Test Location
 12.3.8.4.5 Japan Infectious Disease Diagnostics Market by End User
 12.3.8.5 South Korea Infectious Disease Diagnostics Market
 12.3.8.5.1 South Korea Infectious Disease Diagnostics Market by Product
 12.3.8.5.2 South Korea Infectious Disease Diagnostics Market by Disease Indication
 12.3.8.5.3 South Korea Infectious Disease Diagnostics Market by Technology
 12.3.8.5.4 South Korea Infectious Disease Diagnostics Market by Test Location
 12.3.8.5.5 South Korea Infectious Disease Diagnostics Market by End User
 12.4. MIDDLE EAST AND AFRICA
 12.4.1 Middle East and Africa Infectious Disease Diagnostics Market Overview
 12.4.2 Middle East and Africa Infectious Disease Diagnostics Market Forecasts and Analysis
 12.4.3 Middle East and Africa Infectious Disease Diagnostics Market Forecasts and Analysis - By Product
 12.4.4 Middle East and Africa Infectious Disease Diagnostics Market Forecasts and Analysis - By Disease Indication
 12.4.5 Middle East and Africa Infectious Disease Diagnostics Market Forecasts and Analysis - By Technology
 12.4.6 Middle East and Africa Infectious Disease Diagnostics Market Forecasts and Analysis - By Test Location
 12.4.7 Middle East and Africa Infectious Disease Diagnostics Market Forecasts and Analysis - By End User
 12.4.8 Middle East and Africa Infectious Disease Diagnostics Market Forecasts and Analysis - By Countries
 12.4.8.1 South Africa Infectious Disease Diagnostics Market
 12.4.8.1.1 South Africa Infectious Disease Diagnostics Market by Product
 12.4.8.1.2 South Africa Infectious Disease Diagnostics Market by Disease Indication
 12.4.8.1.3 South Africa Infectious Disease Diagnostics Market by Technology
 12.4.8.1.4 South Africa Infectious Disease Diagnostics Market by Test Location
 12.4.8.1.5 South Africa Infectious Disease Diagnostics Market by End User
 12.4.8.2 Saudi Arabia Infectious Disease Diagnostics Market
 12.4.8.2.1 Saudi Arabia Infectious Disease Diagnostics Market by Product
 12.4.8.2.2 Saudi Arabia Infectious Disease Diagnostics Market by Disease Indication
 12.4.8.2.3 Saudi Arabia Infectious Disease Diagnostics Market by Technology
 12.4.8.2.4 Saudi Arabia Infectious Disease Diagnostics Market by Test Location
 12.4.8.2.5 Saudi Arabia Infectious Disease Diagnostics Market by End User
 12.4.8.3 U.A.E Infectious Disease Diagnostics Market
 12.4.8.3.1 U.A.E Infectious Disease Diagnostics Market by Product
 12.4.8.3.2 U.A.E Infectious Disease Diagnostics Market by Disease Indication
 12.4.8.3.3 U.A.E Infectious Disease Diagnostics Market by Technology
 12.4.8.3.4 U.A.E Infectious Disease Diagnostics Market by Test Location
 12.4.8.3.5 U.A.E Infectious Disease Diagnostics Market by End User
 12.5. SOUTH AND CENTRAL AMERICA
 12.5.1 South and Central America Infectious Disease Diagnostics Market Overview
 12.5.2 South and Central America Infectious Disease Diagnostics Market Forecasts and Analysis
 12.5.3 South and Central America Infectious Disease Diagnostics Market Forecasts and Analysis - By Product
 12.5.4 South and Central America Infectious Disease Diagnostics Market Forecasts and Analysis - By Disease Indication
 12.5.5 South and Central America Infectious Disease Diagnostics Market Forecasts and Analysis - By Technology
 12.5.6 South and Central America Infectious Disease Diagnostics Market Forecasts and Analysis - By Test Location
 12.5.7 South and Central America Infectious Disease Diagnostics Market Forecasts and Analysis - By End User
 12.5.8 South and Central America Infectious Disease Diagnostics Market Forecasts and Analysis - By Countries
 12.5.8.1 Brazil Infectious Disease Diagnostics Market
 12.5.8.1.1 Brazil Infectious Disease Diagnostics Market by Product
 12.5.8.1.2 Brazil Infectious Disease Diagnostics Market by Disease Indication
 12.5.8.1.3 Brazil Infectious Disease Diagnostics Market by Technology
 12.5.8.1.4 Brazil Infectious Disease Diagnostics Market by Test Location
 12.5.8.1.5 Brazil Infectious Disease Diagnostics Market by End User
 12.5.8.2 Argentina Infectious Disease Diagnostics Market
 12.5.8.2.1 Argentina Infectious Disease Diagnostics Market by Product
 12.5.8.2.2 Argentina Infectious Disease Diagnostics Market by Disease Indication
 12.5.8.2.3 Argentina Infectious Disease Diagnostics Market by Technology
 12.5.8.2.4 Argentina Infectious Disease Diagnostics Market by Test Location
 12.5.8.2.5 Argentina Infectious Disease Diagnostics Market by End User

 13. INDUSTRY LANDSCAPE
 13.1. MERGERS AND ACQUISITIONS
 13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
 13.3. NEW PRODUCT LAUNCHES
 13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

 14. INFECTIOUS DISEASE DIAGNOSTICS MARKET, KEY COMPANY PROFILES
 14.1. DANAHER
 14.1.1. Key Facts
 14.1.2. Business Description
 14.1.3. Products and Services
 14.1.4. Financial Overview
 14.1.5. SWOT Analysis
 14.1.6. Key Developments
 14.2. ABBOTT
 14.2.1. Key Facts
 14.2.2. Business Description
 14.2.3. Products and Services
 14.2.4. Financial Overview
 14.2.5. SWOT Analysis
 14.2.6. Key Developments
 14.3. BD
 14.3.1. Key Facts
 14.3.2. Business Description
 14.3.3. Products and Services
 14.3.4. Financial Overview
 14.3.5. SWOT Analysis
 14.3.6. Key Developments
 14.4. F. HOFFMANN-LA ROCHE LTD
 14.4.1. Key Facts
 14.4.2. Business Description
 14.4.3. Products and Services
 14.4.4. Financial Overview
 14.4.5. SWOT Analysis
 14.4.6. Key Developments
 14.5. TRINITY BIOTECH
 14.5.1. Key Facts
 14.5.2. Business Description
 14.5.3. Products and Services
 14.5.4. Financial Overview
 14.5.5. SWOT Analysis
 14.5.6. Key Developments
 14.6. CARDINAL HEALTH
 14.6.1. Key Facts
 14.6.2. Business Description
 14.6.3. Products and Services
 14.6.4. Financial Overview
 14.6.5. SWOT Analysis
 14.6.6. Key Developments
 14.7. BIOMéRIEUX SA
 14.7.1. Key Facts
 14.7.2. Business Description
 14.7.3. Products and Services
 14.7.4. Financial Overview
 14.7.5. SWOT Analysis
 14.7.6. Key Developments
 14.8. BIO-RAD LABORATORIES, INC.
 14.8.1. Key Facts
 14.8.2. Business Description
 14.8.3. Products and Services
 14.8.4. Financial Overview
 14.8.5. SWOT Analysis
 14.8.6. Key Developments
 14.9. ACCUBIOTECH CO., LTD.
 14.9.1. Key Facts
 14.9.2. Business Description
 14.9.3. Products and Services
 14.9.4. Financial Overview
 14.9.5. SWOT Analysis
 14.9.6. Key Developments
 14.10. ACON LABORATORIES, INC.
 14.10.1. Key Facts
 14.10.2. Business Description
 14.10.3. Products and Services
 14.10.4. Financial Overview
 14.10.5. SWOT Analysis
 14.10.6. Key Developments

 15. APPENDIX
 15.1. ABOUT THE INSIGHT PARTNERS
 15.2. GLOSSARY OF TERMS

 

The List of Companies

1. Danaher
2. Abbott
3. BD
4. F. Hoffmann-La Roche Ltd
5. Trinity Biotech
6. Cardinal Health
7. bioMérieux SA
8. Bio-Rad Laboratories, Inc.
9. AccuBioTech Co., Ltd.
10. ACON Laboratories, Inc.

 

TIPHE100001430
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking